{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:18:42Z","timestamp":1790806722371,"version":"4.1.0"},"reference-count":38,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.3201\/eid2809.220487","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T11:54:22Z","timestamp":1660218862000},"page":"1805-1813","source":"Crossref","is-referenced-by-count":21,"title":["Fulminant Transfusion-Associated Hepatitis E Virus Infection Despite Screening, England, 2016\u20132020"],"prefix":"10.3201","volume":"28","author":[{"given":"Heli","family":"Harvala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Brailsford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy","family":"Davison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2809.220487-202208171152-R1","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1099\/jgv.0.000940","article-title":"ICTV virus taxonomy profile: Hepeviridae.","volume":"98","author":"Purdy","year":"2017","journal-title":"J Gen Virol"},{"key":"key-10.3201\/eid2809.220487-202208171152-R2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13567-017-0436-3","article-title":"From the epidemiology of hepatitis E virus (HEV) within the swine reservoir to public health risk mitigation strategies: a comprehensive review.","volume":"48","author":"Salines","year":"2017","journal-title":"Vet Res (Faisalabad)"},{"key":"key-10.3201\/eid2809.220487-202208171152-R3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/zph.12364","article-title":"Hepatitis E in southern Vietnam: Seroepidemiology in humans and molecular epidemiology in pigs.","volume":"65","author":"Berto","year":"2018","journal-title":"Zoonoses Public Health"},{"key":"key-10.3201\/eid2809.220487-202208171152-R4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1055\/s-0033-1338113","article-title":"Zoonotic and foodborne transmission of hepatitis E virus.","volume":"33","author":"Meng","year":"2013","journal-title":"Semin Liver Dis"},{"key":"key-10.3201\/eid2809.220487-202208171152-R5","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1093\/infdis\/jit652","article-title":"Indigenous hepatitis E in England and wales from 2003 to 2012: evidence of an emerging novel phylotype of viruses.","volume":"209","author":"Ijaz","year":"2014","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2809.220487-202208171152-R6","doi-asserted-by":"publisher","first-page":"a032144","DOI":"10.1101\/cshperspect.a032144","article-title":"Transmission and epidemiology of hepatitis E virus genotype 3 and 4 infections.","volume":"8","author":"Dalton","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"key-10.3201\/eid2809.220487-202208171152-R7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1159\/000342301","article-title":"Epidemiology of mammalian hepatitis E virus infection.","volume":"56","author":"Kaba","year":"2013","journal-title":"Intervirology"},{"key":"key-10.3201\/eid2809.220487-202208171152-R8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2807\/1560-7917.ES.2018.23.12.17-00174","article-title":"Hepatitis E virus (HEV) in Scotland: evidence of recent increase in viral circulation in humans.","volume":"23","author":"Thom","year":"2018","journal-title":"Euro Surveill"},{"key":"key-10.3201\/eid2809.220487-202208171152-R9","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s10096-008-0480-z","article-title":"Autochthonous hepatitis E in Southwest England: a comparison with hepatitis A.","volume":"27","author":"Dalton","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key-10.3201\/eid2809.220487-202208171152-R10","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/vox.12056","article-title":"Hepatitis E virus in Scottish blood donors.","volume":"105","author":"Cleland","year":"2013","journal-title":"Vox Sang"},{"key":"key-10.3201\/eid2809.220487-202208171152-R11","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.1111\/trf.13757","article-title":"Hepatitis E virus infection in the Irish blood donor population.","volume":"56","author":"O\u2019Riordan","year":"2016","journal-title":"Transfusion"},{"key":"key-10.3201\/eid2809.220487-202208171152-R12","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/jmv.21056","article-title":"High prevalence of anti-hepatitis E virus antibodies in blood donors from South West France.","volume":"80","author":"Mansuy","year":"2008","journal-title":"J Med Virol"},{"key":"key-10.3201\/eid2809.220487-202208171152-R13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2807\/1560-7917.ES.2016.21.30.30299","article-title":"High prevalence of anti-hepatitis E virus antibodies among blood donors in central Italy, February to March 2014.","volume":"21","author":"Lucarelli","year":"2016","journal-title":"Euro Surveill"},{"key":"key-10.3201\/eid2809.220487-202208171152-R14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jcv.2016.06.010","article-title":"Hepatitis E virus: Assessment of the epidemiological situation in humans in Europe, 2014\/15.","volume":"82","author":"Adlhoch","year":"2016","journal-title":"J Clin Virol"},{"key":"key-10.3201\/eid2809.220487-202208171152-R15","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.3201\/eid2108.141995","article-title":"Prevalence of hepatitis E virus infection in pigs at the time of slaughter, United Kingdom, 2013.","volume":"21","author":"Grierson","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2809.220487-202208171152-R16","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1111\/trf.13498","article-title":"Virology, serology, and demography of hepatitis E viremic blood donors in South East England.","volume":"56","author":"Tedder","year":"2016","journal-title":"Transfusion"},{"key":"key-10.3201\/eid2809.220487-202208171152-R17","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1016\/S0140-6736(14)61034-5","article-title":"Hepatitis E virus in blood components: a prevalence and transmission study in southeast England.","volume":"384","author":"Hewitt","year":"2014","journal-title":"Lancet"},{"key":"key-10.3201\/eid2809.220487-202208171152-R18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1159\/000499121","article-title":"Blood donor screening for hepatitis E virus in the European Union.","volume":"46","author":"Boland","year":"2019","journal-title":"Transfus Med Hemother"},{"key":"key-10.3201\/eid2809.220487-202208171152-R19","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.3201\/eid2011.140516","article-title":"Hepatitis E virus infections in blood donors, France.","volume":"20","author":"Gallian","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2809.220487-202208171152-R20","doi-asserted-by":"publisher","first-page":"20812","DOI":"10.2807\/1560-7917.ES2014.19.21.20812","article-title":"Transfusion-transmitted hepatitis E in Germany, 2013.","volume":"19","author":"Huzly","year":"2014","journal-title":"Euro Surveill"},{"key":"key-10.3201\/eid2809.220487-202208171152-R21","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/trf.13402","article-title":"Incidence and duration of hepatitis E virus infection in Dutch blood donors.","volume":"56","author":"Hogema","year":"2016","journal-title":"Transfusion"},{"key":"key-10.3201\/eid2809.220487-202208171152-R22","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3201\/eid1304.061387","article-title":"Transfusion-associated hepatitis E, France.","volume":"13","author":"Colson","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2809.220487-202208171152-R23","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/trf.13976","article-title":"Hepatitis E risks: pigs or blood-that is the question.","volume":"57","author":"Tedder","year":"2017","journal-title":"Transfusion"},{"key":"key-10.3201\/eid2809.220487-202208171152-R24","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1056\/NEJMoa0706992","article-title":"Hepatitis E virus and chronic hepatitis in organ-transplant recipients.","volume":"358","author":"Kamar","year":"2008","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2809.220487-202208171152-R25","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1182\/blood-2013-03-492363","article-title":"Hepatitis E virus: an underestimated opportunistic pathogen in recipients of allogeneic hematopoietic stem cell transplantation.","volume":"122","author":"Versluis","year":"2013","journal-title":"Blood"},{"key":"key-10.3201\/eid2809.220487-202208171152-R26","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jcv.2016.05.006","article-title":"Hepatitis E virus infection in the HIV-positive patient.","volume":"80","author":"Debes","year":"2016","journal-title":"J Clin Virol"},{"key":"key-10.3201\/eid2809.220487-202208171152-R27","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/1752-1947-6-334","article-title":"Chronic hepatitis E virus infection in a patient with leukemia and elevated transaminases: a case report.","volume":"6","author":"Gauss","year":"2012","journal-title":"J Med Case Reports"},{"key":"key-10.3201\/eid2809.220487-202208171152-R28","doi-asserted-by":"publisher","first-page":"30514","DOI":"10.2807\/1560-7917.ES.2017.22.16.30514","article-title":"Hepatitis E and blood donation safety in selected European countries: a shift to screening?","volume":"22","author":"Domanovi\u0107","year":"2017","journal-title":"Euro Surveill"},{"key":"key-10.3201\/eid2809.220487-202208171152-R29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.tmrv.2019.05.017","article-title":"Hepatitis E virus infection in blood donors and risk to patients in the United States and Canada.","volume":"33","author":"Delage","year":"2019","journal-title":"Transfus Med Rev"},{"key":"key-10.3201\/eid2809.220487-202208171152-R30","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/trf.13978","article-title":"Cost-effectiveness of the screening of blood donations for hepatitis E virus in the Netherlands.","volume":"57","author":"de Vos","year":"2017","journal-title":"Transfusion"},{"key":"key-10.3201\/eid2809.220487-202208171152-R31","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/vox.12719","article-title":"Impact of hepatitis E virus testing on the safety of blood components in Germany - results of a simulation study.","volume":"113","author":"Kamp","year":"2018","journal-title":"Vox Sang"},{"key":"key-10.3201\/eid2809.220487-202208171152-R32","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/trf.15058","article-title":"Hepatitis E virus blood donor NAT screening: as much as possible or as much as needed?","volume":"59","author":"Vollmer","year":"2019","journal-title":"Transfusion"},{"key":"key-10.3201\/eid2809.220487-202208171152-R33","article-title":"Risk of transfusion-transmitted hepatitis E virus infection from pool-tested platelets and plasma.","author":"Cordes","year":"2021","journal-title":"J Hepatol"},{"key":"key-10.3201\/eid2809.220487-202208171152-R34","doi-asserted-by":"publisher","first-page":"1800386","DOI":"10.2807\/1560-7917.ES.2019.24.10.1800386","article-title":"Hepatitis E virus in blood donors in England, 2016 to 2017: from selective to universal screening.","volume":"24","author":"Harvala","year":"2019","journal-title":"Euro Surveill"},{"key":"key-10.3201\/eid2809.220487-202208171152-R35","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.tmrv.2019.06.001","article-title":"Transfusion-transmitted hepatitis E virus infection in France.","volume":"33","author":"Gallian","year":"2019","journal-title":"Transfus Med Rev"},{"key":"key-10.3201\/eid2809.220487-202208171152-R36","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fmed.2018.00005","article-title":"Transfusion-transmitted hepatitis E: NAT screening of blood donations and infectious dose.","volume":"5","author":"Dreier","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"key-10.3201\/eid2809.220487-202208171152-R37","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1080\/09537104.2021.1887842","article-title":"Platelets and viruses.","volume":"32","author":"Antoniak","year":"2021","journal-title":"Platelets"},{"key":"key-10.3201\/eid2809.220487-202208171152-R38","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.virol.2019.07.025","article-title":"Integrin \u03b13 is involved in non-enveloped hepatitis E virus infection.","volume":"536","author":"Shiota","year":"2019","journal-title":"Virology"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/28\/9\/22-0487_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T12:56:49Z","timestamp":1732971409000},"score":1,"resource":{"primary":{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/28\/9\/22-0487_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2809.220487","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9]]}}}